Search by Drug Name or NDC
NDC 68210-1700-02 EXTRA STRENGTH PAIN RELIEVER 250; 250; 65 mg/1; mg/1; mg/1 Details
EXTRA STRENGTH PAIN RELIEVER 250; 250; 65 mg/1; mg/1; mg/1
EXTRA STRENGTH PAIN RELIEVER is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by SPIRIT PHARMACEUTICALS LLC. The primary component is ACETAMINOPHEN; ASPIRIN; CAFFEINE.
Product Information
| NDC | 68210-1700 |
|---|---|
| Product ID | 68210-1700_0c05574c-f9a1-5d92-e063-6394a90a9d00 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | EXTRA STRENGTH PAIN RELIEVER |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | ACETAMINOPHEN, ASPIRIN, AND CAFFEINE |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 250; 250; 65 |
| Active Ingredient Units | mg/1; mg/1; mg/1 |
| Substance Name | ACETAMINOPHEN; ASPIRIN; CAFFEINE |
| Labeler Name | SPIRIT PHARMACEUTICALS LLC |
| Pharmaceutical Class | Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [E |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH DRUG |
| Application Number | M013 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 68210-1700-02 (68210170002)
| NDC Package Code | 68210-1700-2 |
|---|---|
| Billing NDC | 68210170002 |
| Package | 1 BOTTLE in 1 CARTON (68210-1700-2) / 24 TABLET in 1 BOTTLE |
| Marketing Start Date | 2018-04-10 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |